
Ophthalmic Implants Market - Global Outlook & Forecast 2022-2027
Description
Ophthalmic Implants Market - Global Outlook & Forecast 2022-2027
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Ophthalmic Implants Market Report
The ophthalmic implants market size is expected to grow at a CAGR of 6.5%.
MARKET GROWTH ENABLERS
The Intraocular Lenses are expected to witness the highest incremental growth and Glaucoma Implants are likely to witness the highest absolute growth during the forecast period. The rising cases of presbyopia, myopia, blindness, cataract surgery, and farsightedness are expected to drive demand for the global eye implant market. Other major reasons for the market's growth include increasing awareness of comprehensive eye care services, the surge in the geriatric population, and the inclusion of eye care services in the insurance system. The total number of patients undergoing cataract surgery has more than tripled in a decade, a key factor that has impacted players in the intraocular lens industry.
Hospitals are expected to witness the highest incremental growth during the forecast period. The Hospital segment is the dominant segment in the ophthalmic implant market. Glaucoma drainage implant surgery is performed in an outpatient surgery center or hospital.
Market Segmentation by Product
Advances in ophthalmic diagnostic technology have resulted in wider product adoption. The easy accessibility of online tools has educated the public about various treatment options and will help the market grow. The increasing acceptance of advanced ocular devices such as artificial eyes and glaucoma devices has opened up the potential for companies active in the market. The increasing number of regulatory approvals for corneal implants devices will help large companies generate significant revenue in the eye implant market in the years to come. The emergence of various advanced intraocular lenses and increased competition between manufacturers to develop better lenses, as well as an increase in investment in eye research institutes by government and non-governmental organizations are expected to fuel market growth.
Key Vendors
The increasing ageing population and raising awareness in the North American region are expected to drive the ophthalmic implants market size in the region.
Market Segmentation by Region
1. The analysis of the global Ophthalmic Implants market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Ophthalmic Implants market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the Ophthalmic Implants market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Ophthalmic Implants Market Report
The ophthalmic implants market size is expected to grow at a CAGR of 6.5%.
MARKET GROWTH ENABLERS
- Growing Advancements in Ophthalmic Diagnostic Technology
- Increasing Adoption of Advanced Ocular Devices
- Increase in the Number of Cases Of Eye-Related Disorders
- Rise In Awareness of Diagnosis & Treatment of Eye Disorders
- In May 2020, the launch of the presbyopia-correcting intraocular lens (IOL) LuxSmart and its monofocal version LuxGood was announced. Both have pre-loaded delivery systems and Pure Refractive Optics (PRO) technology.
- In January 2021, the AcrySof IQ Vivity IOL (Vivity), the non-diffractive intraocular lens with extended depth of field (IOL), was launched in the US. Vivity is used in the AcrySof IQ IOL.
The Intraocular Lenses are expected to witness the highest incremental growth and Glaucoma Implants are likely to witness the highest absolute growth during the forecast period. The rising cases of presbyopia, myopia, blindness, cataract surgery, and farsightedness are expected to drive demand for the global eye implant market. Other major reasons for the market's growth include increasing awareness of comprehensive eye care services, the surge in the geriatric population, and the inclusion of eye care services in the insurance system. The total number of patients undergoing cataract surgery has more than tripled in a decade, a key factor that has impacted players in the intraocular lens industry.
Hospitals are expected to witness the highest incremental growth during the forecast period. The Hospital segment is the dominant segment in the ophthalmic implant market. Glaucoma drainage implant surgery is performed in an outpatient surgery center or hospital.
Market Segmentation by Product
- Intraocular Lenses
- Glaucoma Implants
- Corneal Implants
- Others
- CATARACT SURGERY
- GLAUCOMA SURGERY
- OTHERS
- Hospitals
- Ambulatory Surgery Centers
- Ophthalmic Clinics
Advances in ophthalmic diagnostic technology have resulted in wider product adoption. The easy accessibility of online tools has educated the public about various treatment options and will help the market grow. The increasing acceptance of advanced ocular devices such as artificial eyes and glaucoma devices has opened up the potential for companies active in the market. The increasing number of regulatory approvals for corneal implants devices will help large companies generate significant revenue in the eye implant market in the years to come. The emergence of various advanced intraocular lenses and increased competition between manufacturers to develop better lenses, as well as an increase in investment in eye research institutes by government and non-governmental organizations are expected to fuel market growth.
Key Vendors
- ALCON
- Johnson & Johnson
- Bausch & Lomb
- Second Sight
- Micro Engineering Solutions
- Gulden Ophthalmic
- AJL Ophthalmic S.A
- EyeD Pharma
- Care Group
- F. Ad. Müller Söhne Gmbh & Co.KG
- Hoya Corporation
- MORCHER GmbH
- Ophtec BV
- BVI
- Rayner Intraocular Lenses Limited
- Glaukos Corporation
- CorNeat Vision
- HumanOptics
- Omni Lens
- IVANTIS
- InnFocus
- POLYACTIVA PTY LTD
- LAMBDAVISION
- SMR OPHTHALMIC PVT. LTD
- Labtician Ophthalmics, Inc
- Devine Meditech
- Innolens
- iSTAR Medical
The increasing ageing population and raising awareness in the North American region are expected to drive the ophthalmic implants market size in the region.
Market Segmentation by Region
- Europe
- Germany
- UK
- France
- Spain
- Italy
- North America
- US
- Canada
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Mexico
- Argentina
- Brazil
- Middle East and Africa
- Turkey
- Saudi Arabia
- South Africa
1. The analysis of the global Ophthalmic Implants market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Ophthalmic Implants market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the Ophthalmic Implants market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Table of Contents
265 Pages
- 1 RESEARCH METHODOLOGY
- 2 RESEARCH OBJECTIVES
- 3 RESEARCH PROCESS
- 4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY PRODUCT
- 4.3.2 MARKET SEGMENTATION BY APPLICATION
- 4.3.3 MARKET SEGMENTATION BY END-USER
- 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
- 5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
- 6 MARKET AT A GLANCE
- 7 INTRODUCTION
- 7.1 OVERVIEW
- 7.2 IMPACT OF COVID-19
- 8 MARKET OPPORTUNITIES & TRENDS
- 8.1 RISE OF ARTIFICIAL INTELLIGENCE FOR DETECTING DIABETIC RETINOPATHY
- 8.2 USE OF SYNTHETIC CORNEA IMPLANTS
- 8.3 INCREASE IN USE OF ROBOTIC SURGICAL ASSISTANTS FOR EYE SURGERIES
- 9 MARKET GROWTH ENABLERS
- 9.1 GROWING ADVANCEMENTS IN OPHTHALMIC DIAGNOSTIC TECHNOLOGY
- 9.2 INCREASING ADOPTION OF ADVANCED OCULAR DEVICES
- 9.3 INCREASE IN THE NUMBER OF CASES OF EYE-RELATED DISORDERS
- 9.4 RISE IN AWARENESS OF DIAGNOSIS & TREATMENT OF EYE DISORDERS
- 9.5 RISE IN PREFERENCE FOR MINIMALLY INVASIVE OPHTHALMIC SURGERY
- 10 MARKET RESTRAINTS
- 10.1 STRINGENT REGULATORY APPROVALS AND PRODUCT RECALLS
- 10.2 INCREASE IN RISK OF SURGERY FAILURE
- 11 MARKET LANDSCAPE
- 11.1 MARKET OVERVIEW
- 11.2 MARKET SIZE & FORECAST
- 11.2.1 MARKET SHARE BY PRODUCT
- 11.2.2 MARKET SHARE BY APPLICATION
- 11.2.3 MARKET SHARE BY END-USER
- 11.2.4 MARKET SHARE BY GEOGRAPHY
- 11.3 FIVE FORCES ANALYSIS
- 11.3.1 THREAT OF NEW ENTRANTS
- 11.3.2 BARGAINING POWER OF SUPPLIERS
- 11.3.3 BARGAINING POWER OF BUYERS
- 11.3.4 THREAT OF SUBSTITUTES
- 11.3.5 COMPETITIVE RIVALRY
- 12 PRODUCT
- 12.1 MARKET SNAPSHOT & GROWTH ENGINE
- 12.2 MARKET OVERVIEW
- 12.3 INTRAOCULAR LENSES
- 12.3.1 MARKET OVERVIEW
- 12.3.2 MARKET SIZE & FORECAST
- 12.3.3 INTRAOCULAR LENSES: MARKET BY GEOGRAPHY
- 12.4 GLAUCOMA IMPLANTS
- 12.4.1 MARKET OVERVIEW
- 12.4.2 MARKET SIZE & FORECAST
- 12.4.3 GLAUCOMA IMPLANTS: MARKET BY GEOGRAPHY
- 12.5 CORNEAL IMPLANTS
- 12.5.1 MARKET OVERVIEW
- 12.5.2 MARKET SIZE & FORECAST
- 12.5.3 CORNEAL IMPLANTS: MARKET BY GEOGRAPHY
- 12.6 OTHERS
- 12.6.1 MARKET OVERVIEW
- 12.6.2 MARKET SIZE & FORECAST
- 12.6.3 OTHERS: MARKET BY GEOGRAPHY
- 13 APPLICATION
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 CATARACT SURGERY
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 CATARACT SURGERY: MARKET BY GEOGRAPHY
- 13.4 GLAUCOMA SURGERY
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 GLAUCOMA SURGERY: MARKET BY GEOGRAPHY
- 13.5 OTHERS
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 OTHERS: MARKET BY GEOGRAPHY
- 14 END-USER
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 HOSPITALS
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 HOSPITALS: MARKET BY GEOGRAPHY
- 14.4 AMBULATORY SURGERY CENTERS
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 AMBULATORY SURGERY CENTERS: MARKET BY GEOGRAPHY
- 14.5 OPHTHALMIC CLINICS
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 OPHTHALMIC CLINICS: MARKET BY GEOGRAPHY
- 15 GEOGRAPHY
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 GEOGRAPHIC OVERVIEW
- 16 NORTH AMERICA
- 16.1 MARKET OVERVIEW
- 16.2 MARKET SIZE & FORECAST
- 16.3 NORTH AMERICA: PRODUCT SEGMENTATION
- 16.4 NORTH AMERICA: APPLICATION SEGMENTATION
- 16.5 NORTH AMERICA: END-USER SEGMENTATION
- 16.6 NORTH AMERICA: KEY COUNTRIES
- 16.6.1 US: MARKET SIZE & FORECAST
- 16.6.2 CANADA: MARKET SIZE & FORECAST
- 17 EUROPE
- 17.1 MARKET OVERVIEW
- 17.2 MARKET SIZE & FORECAST
- 17.3 EUROPE: PRODUCT SEGMENTATION
- 17.4 EUROPE: APPLICATION SEGMENTATION
- 17.5 EUROPE: END-USER SEGMENTATION
- 17.6 EUROPE: KEY COUNTRIES
- 17.6.1 GERMANY: MARKET SIZE & FORECAST
- 17.6.2 UK: MARKET SIZE & FORECAST
- 17.6.3 FRANCE: MARKET SIZE & FORECAST
- 17.6.4 SPAIN: MARKET SIZE & FORECAST
- 17.6.5 ITALY: MARKET SIZE & FORECAST
- 18 APAC
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 APAC: PRODUCT SEGMENTATION
- 18.4 APAC: APPLICATION SEGMENTATION
- 18.5 APAC: END-USER SEGMENTATION
- 18.6 APAC: KEY COUNTRIES
- 18.6.1 CHINA: MARKET SIZE & FORECAST
- 18.6.2 JAPAN: MARKET SIZE & FORECAST
- 18.6.3 INDIA: MARKET SIZE & FORECAST
- 18.6.4 AUSTRALIA: MARKET SIZE & FORECAST
- 18.6.5 SOUTH KOREA: MARKET SIZE & FORECAST
- 19 LATIN AMERICA
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 LATIN AMERICA: PRODUCT SEGMENTATION
- 19.4 LATIN AMERICA: APPLICATION SEGMENTATION
- 19.5 LATIN AMERICA: END-USER SEGMENTATION
- 19.6 LATIN AMERICA: KEY COUNTRIES
- 19.6.1 MEXICO: MARKET SIZE & FORECAST
- 19.6.2 ARGENTINA: MARKET SIZE & FORECAST
- 19.6.3 BRAZIL: MARKET SIZE & FORECAST
- 20 MIDDLE EAST & AFRICA
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
- 20.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
- 20.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
- 20.6 MIDDLE EAST & AFRICA: KEY COUNTRIES
- 20.6.1 TURKEY: MARKET SIZE & FORECAST
- 20.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 20.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
- 21 COMPETITIVE LANDSCAPE
- 21.1 COMPETITION OVERVIEW
- 21.2 MARKET SHARE ANALYSIS
- 21.2.1 ALCON
- 21.2.2 JOHNSON & JOHNSON VISION
- 21.2.3 BAUSCH & LOMB
- 21.2.4 CARL ZEISS
- 22 PROMINENT VENDORS
- 22.1 ALCON
- 22.1.1 BUSINESS OVERVIEW
- 22.1.2 PRODUCT OFFERINGS
- 22.1.3 KEY STRATEGIES
- 22.1.4 KEY STRENGTHS
- 22.1.5 KEY OPPORTUNITIES
- 22.2 JOHNSON & JOHNSON
- 22.2.1 BUSINESS OVERVIEW
- 22.2.2 PRODUCT OFFERINGS
- 22.2.3 KEY STRATEGIES
- 22.2.4 KEY STRENGTHS
- 22.2.5 KEY OPPORTUNITIES
- 22.3 BAUSCH & LOMB
- 22.3.1 BUSINESS OVERVIEW
- 22.3.2 PRODUCT OFFERINGS
- 22.3.3 KEY STRATEGIES
- 22.3.4 KEY STRENGTHS
- 22.3.5 KEY OPPORTUNITIES
- 23 OTHER PROMINENT VENDORS
- 23.1 SECOND SIGHT
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERINGS
- 23.2 MICRO ENGINEERING SOLUTIONS
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
- 23.3 GULDEN OPHTHALMICS
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
- 23.4 AJL OPHTHALMIC S.A
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 PRODUCT OFFERINGS
- 23.5 EYED PHARMA
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 PRODUCT OFFERINGS
- 23.6 CARE GROUP
- 23.6.1 BUSINESS OVERVIEW
- 23.6.2 PRODUCT OFFERINGS
- 23.7 F.AD. MÜLLER SÖHNE GMBH & CO.KG
- 23.7.1 BUSINESS OVERVIEW
- 23.7.2 PRODUCT OFFERINGS
- 23.8 HOYA CORPORATION
- 23.8.1 BUSINESS OVERVIEW
- 23.8.2 PRODUCT OFFERING
- 23.9 MORCHER GMBH
- 23.9.1 BUSINESS OVERVIEW
- 23.9.2 PRODUCT OFFERINGS
- 23.10 OPHTEC
- 23.10.1 BUSINESS OVERVIEW
- 23.10.2 PRODUCT OFFERINGS
- 23.11 BVI
- 23.11.1 BUSINESS OVERVIEW
- 23.11.2 PRODUCT OFFERINGS
- 23.12 RAYNER INTRAOCULAR LENSES LIMITED
- 23.12.1 BUSINESS OVERVIEW
- 23.12.2 PRODUCT OFFERINGS
- 23.13 GLAUKOS CORPORATION
- 23.13.1 BUSINESS OVERVIEW
- 23.13.2 PRODUCT OFFERINGS
- 23.14 CORNEAT VISION
- 23.14.1 BUSINESS OVERVIEW
- 23.14.2 PRODUCT OFFERINGS
- 23.15 HUMANOPTICS
- 23.15.1 BUSINESS OVERVIEW
- 23.15.2 PRODUCT OFFERINGS
- 23.16 OMNI LENS
- 23.16.1 BUSINESS OVERVIEW
- 23.16.2 PRODUCT OFFERINGS
- 23.17 IVANTIS
- 23.17.1 BUSINESS OVERVIEW
- 23.17.2 PRODUCT OFFERINGS
- 23.18 INNFOCUS
- 23.18.1 BUSINESS OVERVIEW
- 23.18.2 PRODUCT OFFERINGS
- 23.19 POLYACTIVA PTY LTD
- 23.19.1 BUSINESS OVERVIEW
- 23.19.2 PRODUCT OFFERINGS
- 23.20 LAMBDAVISION
- 23.20.1 BUSINESS OVERVIEW
- 23.20.2 PRODUCT OFFERINGS
- 23.21 SMR OPHTHALMIC PVT. LTD.
- 23.21.1 BUSINESS OVERVIEW
- 23.21.2 PRODUCT OFFERINGS
- 23.22 LABTICIAN OPHTHALMICS, INC.
- 23.22.1 BUSINESS OVERVIEW
- 23.22.2 PRODUCT OFFERINGS
- 23.23 DEVINE MEDITECH
- 23.23.1 BUSINESS OVERVIEW
- 23.23.2 PRODUCT OFFERINGS
- 23.24 INNOLENS
- 23.24.1 BUSINESS OVERVIEW
- 23.24.2 PRODUCT OFFERINGS
- 23.25 ISTAR MEDICAL
- 23.25.1 BUSINESS OVERVIEW
- 23.25.2 PRODUCT OFFERINGS
- 24 REPORT SUMMARY
- 24.1 KEY TAKEAWAYS
- 24.2 STRATEGIC RECOMMENDATIONS
- 25 QUANTITATIVE SUMMARY
- 25.1 MARKET BY GEOGRAPHY
- 25.2 MARKET BY PRODUCT
- 25.3 MARKET BY APPLICATION
- 25.4 MARKET BY END-USER
- 25.5 NORTH AMERICA: BY PRODUCT
- 25.6 NORTH AMERICA: BY APPLICATION
- 25.7 NORTH AMERICA: BY END-USER
- 25.8 EUROPE: BY PRODUCT
- 25.9 EUROPE: BY APPLICATION
- 25.10 EUROPE: BY END-USER
- 25.11 APAC: BY PRODUCT
- 25.12 APAC: BY APPLICATION
- 25.13 APAC: BY END-USER
- 25.14 LATIN AMERICA: BY PRODUCT
- 25.15 LATIN AMERICA: BY APPLICATION
- 25.16 LATIN AMERICA: BY END-USER
- 25.17 MIDDLE EAST & AFRICA: BY PRODUCT
- 25.18 MIDDLE EAST & AFRICA: BY APPLICATION
- 25.19 MIDDLE EAST & AFRICA: BY END-USER
- 26 APPENDIX
- 26.1 ABBREVIATIONS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.